The 2026 Korean Society for Genetic Diagnostics (KSGD) Conference will take place from May 21–22, 2026, at the Eliana Hotel in Seoul, South Korea.
As a Gold sponsor, Illumina will participate to engage key stakeholders in clinical genomics and showcase its expanding portfolio supporting the future of precision medicine.
At the Illumina booth, we will present an integrated portfolio including TruPath Genome, TSO500 ctDNA v2, Exome v2.5, clinical microbiology solutions, and DRAGEN/EMD informatics capabilities. These solutions demonstrate scalable, end-to-end workflows across oncology, rare disease, and microbiology applications.
In addition, Illumina will host a 25-minute Industry Workshop titled “From Sample to Insight: Simplified Human WGS Based on TruPath and Future Roadmap.” The session will introduce streamlined TruPath-based workflows and highlight its capabilities in resolving complex genomic regions, structural variants, and phasing, enabling more comprehensive and scalable WGS applications in research and clinical settings.